MEG
LGND icon

Millstone Evans Group’s Ligand Pharmaceuticals LGND Stock Holding History

Millstone Evans Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$15.1K Hold
133
– – 0.01% 478
2025
Q1 		$14K Hold
133
– – 0.01% 486
2024
Q4 		$14.3K Buy
+133
New +$14.3K 0.01% 459